Standard compounded tirzepatide at Forva costs $299 every 4 weeks, or $239 every 4 weeks on a 48-week prepaid plan ($2,868 charged at checkout). The price includes provider review, medication if prescribed, supplies, shipping and ongoing support, with no separate membership fee. Plans renew automatically until you cancel. Compounded tirzepatide is not FDA-approved.
How much does standard compounded tirzepatide cost through Forva?
| Standard plan | Charged at checkout | Cost per 4 weeks | Ongoing renewal after initial term |
|---|---|---|---|
| 4 weeks | $299 | $299 | $299 every 4 weeks |
| 12 weeks | $807 | $269 | $269 every 4 weeks |
| 24 weeks | $1,554 | $259 | $259 every 4 weeks |
| 48 weeks | $2,868 | $239 | $239 every 4 weeks |
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. A licensed provider decides whether treatment is appropriate; selecting a plan does not establish eligibility.
The 12-, 24- and 48-week plans are paid upfront. Their per-4-week figures are the upfront total divided by the number of 4-week cycles. A 48-week plan covers 48 weeks, not a full calendar year. Longer prepaid terms involve a larger initial payment; the lowest per-cycle rate is not the lowest amount due today.
See compounded tirzepatide plans and pricing for the plan cards and full terms.
Is every 4 weeks the same as per month?
No. Four weeks is 28 days. A recurring 4-week schedule has 13 cycles in 52 weeks, compared with 12 calendar months. For budgeting, $299 every 4 weeks averages about $324 per calendar month; $239 every 4 weeks averages about $259. Those are budgeting equivalents, not the amount or schedule of an individual charge.
Does tirzepatide cost more when the prescribed dose increases?
At Forva, your compounded tirzepatide plan price does not increase with your prescribed dose. Provider review, medication if prescribed, supplies, shipping and support remain included. Your provider decides whether a dose change is appropriate.
If comparing programs, ask whether a quoted rate covers only a starting dose, an introductory period or the full ongoing plan. Our guide to GLP-1 dose-related pricing explains what to check.
What happens after the initial plan term?
The plan renews automatically every 4 weeks at the same per-cycle rate while your subscription remains active. A prepaid plan does not automatically charge you for another 12-, 24- or 48-week term.
The first renewal is charged 3 days early, counted from checkout: day 25 for a 4-week plan, or 3 days before a prepaid term ends. Later renewals are every 4 weeks.
To cancel future billing, email support@forvahealth.com before your renewal date. Cancellation does not by itself create a refund entitlement. If a renewal has already been charged, cancellation must be at least 72 hours before that refill is dispensed to stop the shipment. Read the cancellation and refund terms before choosing a prepaid plan.
What is a tirzepatide microdose plan?
A tirzepatide microdose plan uses a lower-dose approach that may be prescribed by a licensed provider when medically appropriate.
Microdose treatment is not simply a discounted version of a standard plan. The medication, dose, and treatment approach are determined by the licensed provider based on the patient's medical information.
At Forva, tirzepatide microdose plans range from $229 every 4 weeks on the 4-week plan to an effective $139 every 4 weeks on the 48-week prepaid plan.
As with all Forva GLP-1 treatment, eligibility and prescribing decisions are made by a licensed provider.
What is included in the plan price?
The listed price includes the licensed provider review, compounded tirzepatide if prescribed, supplies, shipping, and ongoing provider support.
Forva does not add a separate membership fee to its compounded tirzepatide plans. That matters when comparing online GLP-1 programs because some advertised medication prices do not include every fee involved in treatment.
Forva's compounded GLP-1 plans are self-pay. Insurance is not needed or accepted. Forva accepts FSA and HSA cards, and whether a purchase counts as a qualified expense is determined by the patient's plan administrator.
Treatment begins with a short online medical intake. A licensed provider reviews the patient's information and determines whether treatment is medically appropriate. If prescribed, the medication is prepared by a licensed U.S. compounding pharmacy and shipped discreetly to the patient's door.
Read what happens between intake and delivery, including the ID check and provider review. The delivery estimate starts after pharmacy processing, not at checkout.
Do you pay for medication if the provider does not prescribe it?
You pay at checkout, and if the licensed provider determines that GLP-1 treatment is not appropriate, no medication is sent and you're refunded in full.
The provider, not Forva, makes the individual eligibility and treatment decision. That means completing the online intake does not guarantee that tirzepatide or any other medication will be prescribed.
Patients who are ready to complete the medical intake can start the Forva weight-loss evaluation.
Is compounded tirzepatide the same as Zepbound or Mounjaro?
No. Compounded tirzepatide is not Zepbound, Mounjaro, a generic version of either drug, or an FDA-approved equivalent.
Compounded medications are not FDA-approved. The FDA states that it does not review compounded drugs for safety, effectiveness, or quality before they are marketed. The FDA also distinguishes compounded drugs from FDA-approved generic drugs.
Zepbound is an FDA-approved tirzepatide product with its own prescribing information. Clinical evidence, indications, warnings, and FDA review associated with Zepbound apply to that approved product and should not be transferred to a compounded tirzepatide product.
A lower advertised price does not establish that compounded treatment is medically appropriate. Discuss FDA-approved options and your individual needs with your licensed provider.
Why can compounded tirzepatide pricing differ from brand-name medication pricing?
Compounded medications and FDA-approved brand-name medications move through different manufacturing, regulatory, prescribing, and payment systems, so their prices should not be expected to match.
A compounded drug is prepared by a compounding pharmacy for a patient's prescription rather than sold as an FDA-approved brand-name product. The FDA notes that compounded medications may serve an important medical need in some circumstances, but they do not undergo the same premarket review as FDA-approved drugs.
Forva's prices are self-pay prices for its provider-supervised telehealth program. They include the provider review, medication if prescribed, shipping, and ongoing provider support rather than billing those components separately.
That makes the listed plan price useful when comparing the actual out-of-pocket cost of online GLP-1 programs.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved.
The FDA says unapproved GLP-1 products, including compounded semaglutide and tirzepatide, do not undergo its review for safety, effectiveness, or quality before marketing. The FDA recommends that patients obtain prescriptions from licensed healthcare providers and fill them through appropriately licensed pharmacies.
The provider determines whether compounded treatment is medically appropriate for an individual patient. Results vary, and no particular outcome can be guaranteed.
Can you get compounded tirzepatide without insurance?
Yes. Forva's compounded tirzepatide plans are self-pay, so patients do not need insurance to use the program.
The published price is what the plan costs rather than an insurance copay estimate. Standard compounded tirzepatide costs $299 every 4 weeks on the 4-week plan, with prepaid options that work out to $269, $259, or $239 every 4 weeks.
Provider-supervised tirzepatide microdose plans start at $229 every 4 weeks, with prepaid options that work out to $179, $159, or as little as $139 every 4 weeks.
Although Forva does not bill insurance, Forva accepts FSA and HSA cards. Whether a purchase counts as a qualified medical expense is determined by the patient's plan administrator, so patients should check their plan's rules before using those funds.
Forva's compounded GLP-1 service is available in all 50 states, subject to a licensed provider determining that treatment is appropriate.
The Forva Help Center has more information about the process.
Which tirzepatide plan has the lowest cost every 4 weeks?
The tirzepatide microdose 48-week prepaid plan has the lowest effective cost at $139 every 4 weeks, with $1,668 paid upfront.
Among standard compounded tirzepatide plans, the 48-week prepaid plan has the lowest effective cost at $239 every 4 weeks, with $2,868 paid upfront.
The right plan is not necessarily the longest or lowest-priced option for every patient. Plan length is a financial choice. Whether tirzepatide is appropriate, whether a microdose approach is appropriate, and what treatment a patient should receive if prescribed are medical decisions made by a licensed provider.
Forva's pricing is designed to make the full compounded-plan cost visible before a patient begins the provider-supervised process, without adding a separate membership fee later.
Every plan length, the total charged today, and the renewal and cancellation terms are on the compounded tirzepatide plans and pricing page.
GLP-1 medications can cause side effects, most commonly nausea, vomiting, diarrhea and constipation, and carry serious risks. Labeling for FDA-approved semaglutide and tirzepatide products includes a boxed warning about thyroid C-cell tumors. Your provider reviews these risks before prescribing.
Wegovy is a registered trademark of Novo Nordisk A/S. Zepbound is a registered trademark of Eli Lilly and Company. Forva Health is not affiliated with or endorsed by Novo Nordisk or Eli Lilly.
This article is for general information and is not medical advice. Eligibility and treatment decisions are made by a licensed provider.